These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Biochemical markers of bone remodeling and bone density in healthy postmenopausal women]. Campusano C, López JM, González G, Rojas A, Arteaga E, Rodríguez J. Rev Med Chil; 1993 Sep; 121(9):1000-5. PubMed ID: 8191148 [Abstract] [Full Text] [Related]
4. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis. Verit FF, Geyikli I, Yazgan P, Celik A. Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321 [Abstract] [Full Text] [Related]
5. [Relation of estrogen and bone loss in postmenopausal women]. Li XY. Zhonghua Fu Chan Ke Za Zhi; 1989 Sep; 24(5):279-81, 317. PubMed ID: 2620581 [Abstract] [Full Text] [Related]
7. Apolipoprotein E polymorphism is not associated with spinal bone mineral density in peri- and postmenopausal Greek women. Efstathiadou Z, Koukoulis G, Stakias N, Challa A, Tsatsoulis A. Maturitas; 2004 Jul 15; 48(3):259-64. PubMed ID: 15207892 [Abstract] [Full Text] [Related]
9. [Effects of Dioscorea septemloba on bone metabolism in ovariectomized rats]. Xing GS, Lou JS, Wang ZB, Yu SL, Wang Y, Sheng L. Zhongguo Zhong Yao Za Zhi; 2007 Sep 15; 32(18):1909-13. PubMed ID: 18051905 [Abstract] [Full Text] [Related]
10. Common biochemical markers of bone turnover predict future bone loss: a 5-year follow-up study. Löfman O, Magnusson P, Toss G, Larsson L. Clin Chim Acta; 2005 Jun 15; 356(1-2):67-75. PubMed ID: 15936304 [Abstract] [Full Text] [Related]
12. [Analytic study of the reliability of an integrated mineralometric and biochemical system in the dynamic evaluation of the bone mineral content after menopause]. Carone D, Miglionico F, Vizziello G, Fanizza G. Minerva Ginecol; 1994 Apr 15; 46(4):161-5. PubMed ID: 8065588 [Abstract] [Full Text] [Related]
13. The effect of ethinyl oestradiol on calcium and bone metabolism in peri- and postmenopausal women. Marshall RW, Selby PL, Chilvers DC, Hodgkinson A. Horm Metab Res; 1984 Feb 15; 16(2):97-9. PubMed ID: 6706290 [Abstract] [Full Text] [Related]
16. L-thyroxin treatment and post-menopausal osteoporosis: relevance of the risk profile present in clinical history. La Vignera S, Vicari E, Tumino S, Ciotta L, Condorelli R, Vicari LO, Calogero AE. Minerva Ginecol; 2008 Dec 15; 60(6):475-84. PubMed ID: 18981975 [Abstract] [Full Text] [Related]
17. Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements. Akin O, Göl K, Aktürk M, Erkaya S. Gynecol Endocrinol; 2003 Feb 15; 17(1):19-29. PubMed ID: 12724015 [Abstract] [Full Text] [Related]
18. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss]. Liu SP, Liao EY, Wu XP, Cao XZ, Shan PF, Su X. Zhonghua Yi Xue Za Zhi; 2006 Feb 14; 86(6):371-5. PubMed ID: 16677543 [Abstract] [Full Text] [Related]
19. Bone turnover in spinal osteoporosis. Pødenphant J, Johansen JS, Thomsen K, Riis BJ, Leth A, Christiansen C. J Bone Miner Res; 1987 Dec 14; 2(6):497-503. PubMed ID: 3502682 [Abstract] [Full Text] [Related]